Get started
Author

Abbas Hussain

Advances and challenges in immunotherapy in head and neck cancer
2025 · Hazem Aboaid, Taimur Khalid, et al. · Frontiers in Immunology · 48
PDF
Clinical Outcomes With Furosemide Versus Torsemide in Patients With Heart Failure: An Updated Systematic Review and Meta-Analysis
2023 · Ahmed Kamal Siddiqi, Hira Javaid, et al. · Current Problems in Cardiology · 10
A narrative review on artificial intelligence in neurosurgery: ethical challenges and implementation considerations
2025 · Tirath Patel, Hamza Yousuf Ibrahim, et al. · Annals of Medicine and Surgery · 8
Biomarker-Stratified Efficacy of Immune Checkpoint Inhibitors in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Systematic Review and Meta-Analysis of Randomized Trials
2026 · Ramaditya Srinivasmurthy, Daniel T. Jones, et al. · Cancers · 3
PDF
Incidence of ocular toxicities in patients with relapsed/refractory multiple myeloma treated with belantamab mafodotin: A systematic review and meta-analysis of phase 3 randomized controlled trials.
2025 · Riccesha Hattin, Hazem Aboaid, et al. · Journal of Clinical Oncology · 3
Efficacy and safety of the antithrombin siRNA fitusiran as prophylaxis in haemophilia a and B: A systematic review and meta-analysis
2025 · Muhammad Usama, Anas Nasir, et al. · Blood · 2
Incidence of cardiac toxicities in patients with hematologic malignancies treated with zanubrutinib compared to control, including BTK inhibitor (Ibrutinib): A meta-analysis of randomized controlled trials
2025 · Abbas Hussain, Daniel Jones, et al. · Blood · 1
Abstract C057: Locoregional toxicities associated with immunotherapy plus chemoradiation in locally advanced head and neck cancer: A meta-analysis of phase 3 trials
2025 · Ramaditya Srinivasmurthy, Jason Ta, et al. · Molecular Cancer Therapeutics · 1
Evolving treatment strategies in meningioma: from traditional approaches to emerging therapies
2025 · Tirath Patel, Fathimathul Henna, et al. · Annals of Medicine and Surgery · 1
Risk of pulmonary toxicities in patients with EGFR-mutant non-small cell lung cancer (NSCLC) treated with amivantamab: A systematic review and meta-analysis of phase 3 randomized controlled trials.
2025 · Abbas Hussain, Hazem Aboaid, et al. · Journal of Clinical Oncology · 1
HSR25-152: Incidence of Hematologic Adverse Events in Patients With EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab: A Meta-Analysis of Phase III Randomized Controlled Trials
2025 · Ramaditya Srinivasmurthy, Hazem Aboaid, et al. · Journal of the National Comprehensive Cancer Network · 1
HSR25-171: Risk of Health-Related Quality of Life (HRQOL) Events in Patients with EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated With Amivantamab: A Meta-Analysis of Phase III Randomized Controlled Trials
2025 · Daniel Thomas Jones, Abbas Hussain, et al. · Journal of the National Comprehensive Cancer Network · 1
The oncology capability gap: Failure-to-rescue following high-risk oncologic emergencies in the United States.
2026 · Daniel Thomas Jones, Rishi Kumar Nanda, et al. · JCO Oncology Practice
PDF
Global disparities in neurosurgical literature: a narrative review of underrepresentation of low- and middle-income countries and pathways to research equity.
2026 · Tirath Patel, Naveed Ahmad, et al. · PubMed
PDF
Transcranial Direct Current Stimulation for Developmental Dyslexia: A Systematic Review and Meta-analysis of Randomized Controlled Trials (P1-8.001)
2026 · Abbas Hussain, Aziz Ur Rehman, et al. · Neurology
Minimally invasive vs open pancreaticoduodenectomy for periampullary tumors: A systematic review and updated meta-analysis.
2026 · Oscar Toro Ruilowa, Arbab Khalid, et al. · Journal of Clinical Oncology
Emergency vs elective presentation as a care-delivery phenotype in presumed early-stage lung cancer: A National Inpatient analysis.
2026 · Daniel Thomas Jones, Rishi Kumar Nanda, et al. · Journal of Clinical Oncology
Efficacy and safety of rivaroxaban compared with LMWH in patients with cancer-associated thrombosis: A systematic review and meta-analysis of randomized controlled trials.
2026 · Arisha Akhtar, Nikkita Choudhary, et al. · Journal of Clinical Oncology
The impact of surgery and the type of immune check point inhibitors (ICI) in patients with locally advanced head and neck squamous cell carcinoma (LA HNSCC) receiving immunotherapy: An updated systematic review and meta-analysis of randomized controlled trials.
2026 · Abbas Hussain, Khadija Mohib, et al. · Journal of Clinical Oncology
Atrial fibrillation as a sentinel cardiovascular event in renal cell carcinoma hospitalizations: National Inpatient outcomes and rescue failure (NIS 2016–2023).
2026 · Zin Thandar Win, Ramaditya Srinivasmurthy, et al. · Journal of Clinical Oncology
Efficacy of immune checkpoint inhibitors (ICIs) in locoregionally advanced nasopharyngeal carcinoma (LA NPC): A meta-analysis of phase II and III randomized controlled trials.
2026 · Jason Ta, Ramaditya Srinivasmurthy, et al. · Journal of Clinical Oncology
Adverse effects of immune checkpoint inhibitors in locally advanced head and neck squamous cell carcinoma: A meta-analysis of randomized trials.
2026 · Rishi Kumar Nanda, Daniel Thomas Jones, et al. · Journal of Clinical Oncology
PDF
Association of acute kidney injury with in-hospital mortality and resource utilization among U.S. solid tumor hospitalizations: A National Inpatient Sample analysis, 2018–2022.
2026 · Carter Taysom, Ramaditya Srinivasmurthy, et al. · Journal of Clinical Oncology
Emergency presentation as a diagnostic failure phenotype in ovarian cancer: A National Inpatient analysis (NIS 2016–2023).
2026 · Cinthiya Chander, Ramaditya Srinivasmurthy, et al. · Journal of Clinical Oncology
Adverse effects associated with immune checkpoint inhibitors in locally advanced nasopharyngeal carcinoma: A meta-analysis of randomized controlled trials.
2026 · Riccesha Hattin, Rishi Kumar Nanda, et al. · Journal of Clinical Oncology
Works count: 68
Citation count: 80
H-index: 3
I10-index: 2
Year
Topic
Type